Universe Pharmaceuticals INC (UPC)
USD 3.57
(-2.46%)
USD 3.57
(-2.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.75 Million USD | 5.01% |
| 2022 | 13.09 Million USD | 16.83% |
| 2021 | 11.21 Million USD | 40.11% |
| 2020 | 8 Million USD | 46.74% |
| 2019 | 5.45 Million USD | -70.36% |
| 2018 | 18.39 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 22.68 Million USD | 0.0% |
| 2023 FY | 13.75 Million USD | 5.01% |
| 2023 Q4 | 13.75 Million USD | 0.0% |
| 2023 Q2 | 23.24 Million USD | 0.0% |
| 2022 FY | 13.09 Million USD | 16.83% |
| 2022 Q4 | 13.09 Million USD | 0.0% |
| 2022 Q2 | 10.2 Million USD | 0.0% |
| 2021 Q2 | 16.58 Million USD | 0.0% |
| 2021 FY | 11.21 Million USD | 40.11% |
| 2021 Q4 | 11.21 Million USD | 0.0% |
| 2020 FY | 8 Million USD | 46.74% |
| 2020 Q4 | 8 Million USD | 0.0% |
| 2020 Q2 | 9.29 Million USD | 0.0% |
| 2019 FY | 5.45 Million USD | -70.36% |
| 2019 Q4 | 5.45 Million USD | 0.0% |
| 2018 FY | 18.39 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 98.549% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -49.559% |
| Embecta Corp. | 2.03 Billion USD | 99.324% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 98.047% |
| PainReform Ltd. | 2.69 Million USD | -411.123% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -124.027% |
| SCYNEXIS, Inc. | 55.45 Million USD | 75.195% |
| Journey Medical Corporation | 56.49 Million USD | 75.656% |
| Safety Shot Inc | 3.89 Million USD | -253.396% |
| Alpha Teknova, Inc. | 38.55 Million USD | 64.322% |
| Bright Green Corporation | 6.43 Million USD | -113.64% |
| Procaps Group, S.A. | 462.06 Million USD | 97.023% |
| Alvotech | 1.88 Billion USD | 99.269% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 97.084% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | 91.608% |
| Cosmos Health Inc. | 30.25 Million USD | 54.535% |
| Dynavax Technologies Corporation | 375.02 Million USD | 96.332% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | 97.919% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | 89.951% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -124.027% |
| Theratechnologies Inc. | 98.63 Million USD | 86.056% |
| Harrow Health, Inc. | 241.75 Million USD | 94.311% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -57.085% |
| Biofrontera Inc. | 23.13 Million USD | 40.558% |
| DURECT Corporation | 30.4 Million USD | 54.764% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 97.178% |
| Cronos Group Inc. | 43.73 Million USD | 68.552% |
| OptiNose, Inc. | 194.33 Million USD | 92.922% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 98.317% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | 71.608% |
| RedHill Biopharma Ltd. | 20.97 Million USD | 34.435% |
| Organogenesis Holdings Inc. | 181.36 Million USD | 92.416% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -264.63% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | 73.809% |
| Radius Health, Inc. | 804.29 Million USD | 98.29% |
| ProPhase Labs, Inc. | 42.54 Million USD | 67.67% |
| Phibro Animal Health Corporation | 725.54 Million USD | 98.104% |
| Procaps Group S.A. | 462.06 Million USD | 97.023% |
| TherapeuticsMD, Inc. | 14.02 Million USD | 1.909% |
| Viatris Inc. | 27.21 Billion USD | 99.949% |
| Rockwell Medical, Inc. | 30.88 Million USD | 55.462% |
| Aytu BioPharma, Inc. | 90.37 Million USD | 84.781% |
| SIGA Technologies, Inc. | 57.97 Million USD | 76.276% |
| Tilray Brands, Inc. | 892.11 Million USD | 98.458% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | 93.742% |
| Shineco, Inc. | 47.6 Million USD | 71.105% |
| PetIQ, Inc. | 645.22 Million USD | 97.868% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -6165.867% |
| Incannex Healthcare Limited | 5.83 Million USD | -135.923% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 98.651% |
| Alimera Sciences, Inc. | 107.35 Million USD | 87.188% |
| Silver Spike Investment Corp. | 3 Million USD | -356.98% |
| Assertio Holdings, Inc. | 148.41 Million USD | 90.733% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -625.453% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | 35.473% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -95.763% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -61.996% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | 92.067% |
| Hempacco Co., Inc. | 18.82 Million USD | 26.926% |
| Talphera, Inc. | 6.29 Million USD | -118.67% |
| Alvotech | 1.88 Billion USD | 99.269% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 92.031% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 98.353% |
| Currenc Group, Inc. | 177.67 Million USD | 92.259% |
| Kamada Ltd. | 109.96 Million USD | 87.492% |
| Indivior PLC | 1.95 Billion USD | 99.295% |
| Evoke Pharma, Inc. | 9.64 Million USD | -42.56% |
| Flora Growth Corp. | 17.22 Million USD | 20.135% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -61.996% |
| Evolus, Inc. | 209.68 Million USD | 93.441% |
| HUTCHMED (China) Limited | 536.38 Million USD | 97.436% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 98.425% |
| Akanda Corp. | 12.66 Million USD | -8.568% |